Economic impact of screening for bladder cancer using bladder tumor markers: a decision analysis.
about
Critical evaluation of urinary markers for bladder cancer detection and monitoringDoes the biomarker search paradigm need re-booting?External validation of a multiplex urinary protein panel for the detection of bladder cancer in a multicenter cohort.Fluorescence in situ hybridization for detecting urothelial carcinoma: a clinicopathologic studyThe health economics of bladder cancer: an updated review of the published literature.Urinary protein biomarker panel for the detection of recurrent bladder cancerRationale for an early detection program for bladder cancerMapping of the UGT1A locus identifies an uncommon coding variant that affects mRNA expression and protects from bladder cancer.Should we screen for bladder cancer in a high-risk population?: A cost per life-year saved analysis.Biomarkers for detection and surveillance of bladder cancer.Screening for bladder cancer: a perspective.Healthcare economics of bladder cancer: cost-enhancing and cost-reducing factors.Bladder cancer: chemoprevention, complementary approaches and budgetary considerations.Urinary markers for bladder cancer.Urinary biomarkers of bladder cancer: an update and future perspectives.Urine cytology and urine-based markers for bladder urothelial carcinoma detection and monitoring: developments and future prospects.Accounting for increased non-target-disease-specific mortality in decision-analytic screening models for economic evaluation.Urothelial bladder cancer: biomarkers for detection and screening.Economics of bladder cancerA Festschrift in Honor of Edward M. Messing, MD, FACS
P2860
Q24654929-EDEECC5A-1FA7-4A52-A934-593558A7462AQ33413444-9C36EE3B-82AE-44BB-8C15-840F46135C91Q34135237-0115FDAE-8E0F-43E0-9EFF-FF1C86E9B971Q34361348-939EBEB3-BBAE-4BEA-91A6-FFC465DDC724Q34430559-4B7ED1F1-40FC-44AC-A227-D9307ACF52F7Q35050119-2E91D2D9-4EC5-41B6-B0D2-FE4F46D47279Q35125733-0381D080-4DD8-4B9E-83E9-4F1E9226C27CQ35856276-C4436BF8-D636-4CB2-90C2-B490B10D8765Q36544712-6BD2691F-0A03-4A86-94FD-EAF403AE1153Q36808420-543A11F7-3C3D-4640-A4DA-3459F099F4EAQ37009889-730C34CA-79DE-4082-B6DB-5EA9B60F8DDFQ37231638-20EDE446-5606-4915-927D-907B7AF85AD6Q37279019-EA4E05F1-4E9A-4324-8371-4DB8FCF7D232Q38122367-C49B1A46-B1DC-43DA-997A-4CD558B182D7Q38138607-93D6DA76-D855-4F10-9FAC-CCBC18E50A28Q40109451-3C47D098-9681-4A4B-AFD4-0E6331DAFEA6Q46234389-29421E79-AEA5-44D6-BFC0-BFBA025CD6B3Q46521722-3694232A-E871-4339-9530-9167DF90836FQ57559955-30AD2FB7-8D26-4942-BF2F-AEBB5994CD6FQ58691149-81D36B9C-7035-4B6C-982A-A133482419AE
P2860
Economic impact of screening for bladder cancer using bladder tumor markers: a decision analysis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Economic impact of screening f ...... markers: a decision analysis.
@ast
Economic impact of screening f ...... markers: a decision analysis.
@en
type
label
Economic impact of screening f ...... markers: a decision analysis.
@ast
Economic impact of screening f ...... markers: a decision analysis.
@en
prefLabel
Economic impact of screening f ...... markers: a decision analysis.
@ast
Economic impact of screening f ...... markers: a decision analysis.
@en
P1433
P1476
Economic impact of screening f ...... markers: a decision analysis.
@en
P2093
Arthur I Sagalowsky
Robert S Svatek
P304
P356
10.1016/J.UROLONC.2005.11.025
P50
P577
2006-07-01T00:00:00Z